日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Signaling function of PRC2 is essential for TCR-driven T cell responses

PRC2 的信号功能对于 TCR 驱动的 T 细胞反应至关重要

Marc-Werner Dobenecker, Joon Seok Park, Jonas Marcello, Michael T McCabe, Richard Gregory, Steven D Knight, Inmaculada Rioja, Anna K Bassil, Rabinder K Prinjha, Alexander Tarakhovsky

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

发现 GSK2126458,一种高效 PI3K 抑制剂和雷帕霉素的哺乳动物靶点

Steven D Knight, Nicholas D Adams, Joelle L Burgess, Amita M Chaudhari, Michael G Darcy, Carla A Donatelli, Juan I Luengo, Ken A Newlander, Cynthia A Parrish, Lance H Ridgers, Martha A Sarpong, Stanley J Schmidt, Glenn S Van Aller, Jeffrey D Carson, Melody A Diamond, Patricia A Elkins, Christine M G

Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist

SB-710411(Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide)的药理学表征,一种新型肽类尾加压素-II 受体拮抗剂

David J Behm, Christopher L Herold, Eliot H Ohlstein, Steven D Knight, Dashyant Dhanak, Stephen A Douglas